Safety First Blog

It’s time to wake up! USP <800> is here.

Posted by Laura Paxton on Nov 16, 2022 10:15:34 AM

Don't sleep on USP <800> like our sweet Lily here.

The “hurry up and wait” period is ending, and come this time next year, USP <797> and USP  <800> will be enforceable by the Joint Commission, State Boards of Pharmacy and other accreditation entities. 

Read More

Topics: Rhazdrugs, Policy, USP <800>, Formweb

Cheers to Pharmacists Month

Posted by Laura Paxton on Oct 25, 2022 10:16:16 AM

Here's a month-long celebration we can get behind! 

Read More

Topics: Rhazdrugs, Policy, USP <800>, Formweb

6 Factors For Identifying Hazardous Drugs in Your Organization

Posted by Laura Paxton on Sep 23, 2022 9:35:42 AM

USP <800> requires healthcare organizations to document and communicate safety guidelines for hazardous drugs from the NIOSH hazardous drugs list. While this list is helpful, it is not comprehensive. Not only is the most current list more than two years old, but the FDA also approves hundreds of new drugs that could fall into the hazardous category each year. 

Read More

Topics: Rhazdrugs, Policy, USP <800>, Formweb

USP <800> Wrap-Up: Policies and Procedures for Healthcare Worker Safety

Posted by Laura Paxton on Aug 26, 2022 12:39:15 PM

Did you know that at least one hazardous drug policy or process made the Top Five USP <800> requirements being reviewed by State Boards of Pharmacy, Accreditors, and Centers for Medicare and Medicaid1?

Read More

Topics: Rhazdrugs, Policy, USP <800>, Formweb

Are Safety Data Sheets Up-to-Date, Available AND Being Used?

Posted by Laura Paxton on Jul 26, 2022 10:32:57 AM

You can bet that the Joint Commission will be checking. We understand that locating, storing and communicating the Safety Data Sheets (SDS) is a laborious job. What if SDS were located on a central platform and, wait for it … were automatically available? It’s possible. 

Read More

Topics: Rhazdrugs, Policy, USP <800>, Formweb

Revisiting 'Should, Shall and Must'

Posted by Laura Paxton on Jul 7, 2022 10:09:48 AM

Spelling Out These Legal Terms in Hazardous Drugs Regulations

We're revisiting this blog first published in January 2021 because the terms 'should, shall, must' continue to cause confusion when trying to comply with FDA, OSHA, and USP <800> regulations. Are you one of many healthcare workers still searching for clear definitions of these tricky terms? We're here to help!

Read More

Topics: Rhazdrugs, Policy, USP <800>, Formweb

USP <800> Documentation Requirements: What You Need to Know

Posted by Laura Paxton on Jun 29, 2022 8:37:13 AM

Are hazardous drug protocols documented and accessible in your facility? Seems like a no-brainer, especially considering all of the other potential upgrades and changes your facility may have to undertake to comply with USP <800>. But it’s among the most important pieces of the regulation because what good are policies if the healthcare workers they’re designed to protect do not know about them?

Read More

Topics: Policy, Formweb, Formulary

Up Close: Joint Commission Requirements for Antimicrobial Stewardship Programs

Posted by Laura Paxton on Jun 2, 2022 12:37:33 PM

We’re continuing to expand on the content from our most popular blog in 2021 - “From Our Customers: The Top 8 Questions To Expect In Joint Commission Inspections.” This time we’ll explain antimicrobial stewardship and how to prepare for the Joint Commission inspectors.  

Read More

Topics: Policy, Formweb, Formulary

Does Your LASA List Meet Inspection Requirements?

Posted by Laura Paxton on May 10, 2022 10:23:37 AM

The popularity of our most-read blog from 2021 -From Our Customers: The Top 8 Questions To Expect In Joint Commission Inspections- indicates that hospitals and healthcare systems continue to hustle to ensure all i’s are dotted and t’s are crossed before a visit from Joint Commission, accreditation or state board of pharmacy inspectors. 

Read More

Topics: Policy, Formweb, Formulary

Do You Have A High Alert List And Can Users Easily Access It?

Posted by Laura Paxton on Apr 12, 2022 9:57:01 AM

The popularity of our most-read blog from 2021 - “From Our Customers: The Top 8 Questions To Expect In Joint Commission Inspections” - indicates that hospitals and healthcare systems continue to hustle to ensure all i’s are dotted and t’s are crossed before a visit from Joint Commission, accreditation or state board of pharmacy inspectors. 

Read More

Topics: Policy, Formweb, Formulary

New Name

Same Company You Trust

Rpharmy has a suite of products to meet the diverse needs of our customers.

Request Demo

Subscribe to our blog!

Recent Posts